Sergio G. Durón

2.2k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Sergio G. Durón is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Sergio G. Durón has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 2 papers in Neurology. Recurrent topics in Sergio G. Durón's work include Chemical Synthesis and Analysis (7 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Glycosylation and Glycoproteins Research (2 papers). Sergio G. Durón is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Glycosylation and Glycoproteins Research (2 papers). Sergio G. Durón collaborates with scholars based in United States, Japan and India. Sergio G. Durón's co-authors include Chi‐Huey Wong, Michael D. Burkart, Paul T. Nyffeler, Stéphane P. Vincent, David Y. Gin, David A. Campbell, Michael Arnold, Tony K.‐K. Mong, Hing‐Ken Lee and Tülay Polat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Sergio G. Durón

16 papers receiving 1.6k citations

Hit Papers

Selectfluor: Mechanistic Insight and Applications 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio G. Durón United States 14 973 703 436 184 142 16 1.6k
Daniele Marciano Israel 19 678 0.7× 779 1.1× 682 1.6× 289 1.6× 48 0.3× 52 2.0k
Yumiko Takagi Japan 18 296 0.3× 731 1.0× 64 0.1× 47 0.3× 79 0.6× 52 1.4k
Pei Xu China 26 632 0.6× 437 0.6× 82 0.2× 83 0.5× 52 0.4× 80 1.6k
Nathan T. Jui United States 22 1.8k 1.9× 362 0.5× 540 1.2× 320 1.7× 56 0.4× 40 2.4k
Jacob M. Goldberg United States 16 603 0.6× 707 1.0× 319 0.7× 147 0.8× 32 0.2× 28 1.4k
Liang Sun China 21 951 1.0× 391 0.6× 88 0.2× 115 0.6× 22 0.2× 51 1.5k
Alexander S. Kiselyov United States 26 1.5k 1.5× 1.1k 1.6× 296 0.7× 95 0.5× 511 3.6× 101 2.5k
Haibo Xie China 23 600 0.6× 804 1.1× 199 0.5× 44 0.2× 78 0.5× 71 1.4k
Philippe Nuhant United States 18 812 0.8× 251 0.4× 128 0.3× 123 0.7× 62 0.4× 32 1.4k
François Carreaux France 26 1.4k 1.5× 858 1.2× 42 0.1× 198 1.1× 88 0.6× 90 2.0k

Countries citing papers authored by Sergio G. Durón

Since Specialization
Citations

This map shows the geographic impact of Sergio G. Durón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio G. Durón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio G. Durón more than expected).

Fields of papers citing papers by Sergio G. Durón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio G. Durón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio G. Durón. The network helps show where Sergio G. Durón may publish in the future.

Co-authorship network of co-authors of Sergio G. Durón

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio G. Durón. A scholar is included among the top collaborators of Sergio G. Durón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio G. Durón. Sergio G. Durón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dong, Biao, Sergio G. Durón, David A. Campbell, et al.. (2015). Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 6(4). 1981–1994. 34 indexed citations
2.
Hayashi‐Takagi, Akiko, Yoichi Araki, Mayumi Nakamura, et al.. (2014). PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence. Proceedings of the National Academy of Sciences. 111(17). 6461–6466. 76 indexed citations
3.
Dolan, Bridget, Sergio G. Durón, David A. Campbell, et al.. (2013). Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proceedings of the National Academy of Sciences. 110(14). 5671–5676. 187 indexed citations
4.
Licciulli, Silvia, Jasna Maksimoska, Chun Zhou, et al.. (2013). FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas. Journal of Biological Chemistry. 288(40). 29105–29114. 108 indexed citations
5.
Chow, Hoi Yee, Adrian M. Jubb, Zahara M. Jaffer, et al.. (2012). p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research. 72(22). 5966–5975. 101 indexed citations
6.
Durón, Sergio G., Andrew B. Lindstrom, Céline Bonnefous, et al.. (2011). Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(2). 1237–1241. 7 indexed citations
7.
Crawford, Brett E., et al.. (2011). Small molecule inhibitors of Glycosaminoglycan Biosynthesis as substrate optimization therapy for the Mucopolysaccharidoses. Molecular Genetics and Metabolism. 102(2). S12–S13. 3 indexed citations
8.
Perl, Nicholas R., et al.. (2010). Annulation of Thioimidates and Vinyl Carbodiimides to Prepare 2-Aminopyrimidines, Competent Nucleophiles for Intramolecular Alkyne Hydroamination. Synthesis of (−)-Crambidine. Journal of the American Chemical Society. 132(6). 1802–1803. 45 indexed citations
9.
Arnold, Michael, et al.. (2006). Total Synthesis of (+)-Batzelladine A and (−)-Batzelladine D via [4 + 2]-Annulation of Vinyl Carbodiimides with N-Alkyl Imines. Journal of the American Chemical Society. 128(40). 13255–13260. 81 indexed citations
10.
Arnold, Michael, Sergio G. Durón, & David Y. Gin. (2005). Diastereoselective [4+2] Annulation of Vinyl Carbodiimides with N-Alkyl Imines. Asymmetric Synthetic Access to the Batzelladine Alkaloids. Journal of the American Chemical Society. 127(19). 6924–6925. 38 indexed citations
11.
Nyffeler, Paul T., Sergio G. Durón, Michael D. Burkart, Stéphane P. Vincent, & Chi‐Huey Wong. (2004). Selectfluor: Mechanistic Insight and Applications. Angewandte Chemie International Edition. 44(2). 192–212. 530 indexed citations breakdown →
12.
Nyffeler, Paul T., Sergio G. Durón, Michael D. Burkart, Stéphane P. Vincent, & Chi‐Huey Wong. (2004). Selectfluor: Mechanismen und Anwendungen. Angewandte Chemie. 117(2). 196–217. 133 indexed citations
13.
Durón, Sergio G., Tülay Polat, & Chi‐Huey Wong. (2004). N-(Phenylthio)-ε-caprolactam:  A New Promoter for the Activation of Thioglycosides. Organic Letters. 6(5). 839–841. 72 indexed citations
14.
Mong, Tony K.‐K., Hing‐Ken Lee, Sergio G. Durón, & Chi‐Huey Wong. (2003). Reactivity-based one-pot total synthesis of fucose GM 1 oligosaccharide: A sialylated antigenic epitope of small-cell lung cancer. Proceedings of the National Academy of Sciences. 100(3). 797–802. 107 indexed citations
15.
Durón, Sergio G. & David Y. Gin. (2001). Synthesis and Determination of Absolute Configuration of the Bicyclic Guanidine Core of Batzelladine A. Organic Letters. 3(10). 1551–1554. 29 indexed citations
16.
Nguyen, Hien M., Yanning Chen, Sergio G. Durón, & David Y. Gin. (2001). Sulfide-Mediated Dehydrative Glycosylation. Journal of the American Chemical Society. 123(36). 8766–8772. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026